BAY-2666605 | Interleukin Related interleukin-related.com

Product Name :
BAY-2666605

Search keywords :
BAY 2666605

drugId :
null

Target Vo:
cGMP-inhibited 3′,5′-cyclic phosphodiesterase A

Target Vo Short Name :
PDE3A

Moa_Name:
cGMP-inhibited 3′,5′-cyclic phosphodiesterase A binders

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Bayer AG

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Melanoma

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Tafasitamab Apoptosis
Ezabenlimab Data Sheet
LC3 Antibody: LC3 Antibody is an unconjugated, approximately 14/16 kDa, rabbit-derived, anti-LC3 polyclonal antibody. LC3 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, rat, and predicted: mouse, chicken, dog, pig, cow, horse, sheep, goat background without labeling.

Author: Interleukin Related

Related Posts